Justin D. Gover

Insider Reports History

Location
Cambridge
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Justin D. Gover:

Company Role Class Num Shares Value Price $ Report Date Ownership
COMPASS Pathways plc Director Share Option (Right to Buy) 52,000 29 Jul 2025 Direct
Design Therapeutics, Inc. Director Stock option (right to buy) 45,000 02 Jan 2026 Direct
Xenon Pharmaceuticals Inc. Director Share Option (Right to Buy) 17,012 05 Jun 2025 Direct
Xenon Pharmaceuticals Inc. Director Restricted Share Units 2,645 05 Jun 2025 Direct
GW PHARMACEUTICALS PLC Chief Executive Officer, Director Ordinary Shares 0 05 May 2021 By Justin D. Gover 2020 Irrevocable Trust dated December 14, 2020
GW PHARMACEUTICALS PLC Chief Executive Officer, Director Ordinary Shares 0 05 May 2021 By the Gover Family Investment LLP
GW PHARMACEUTICALS PLC Chief Executive Officer, Director Ordinary Shares 0 05 May 2021 Direct
GW PHARMACEUTICALS PLC Chief Executive Officer, Director Share Options 0 05 May 2021 Direct

Insider Reports Filed by Justin D. Gover

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DSGN Design Therapeutics, Inc. 02 Jan 2026 1 $0 4 Director 05 Jan 2026, 16:10
DSGN Design Therapeutics, Inc. 09 Sep 2025 2 $0 4 Director 10 Sep 2025, 17:18
DSGN Design Therapeutics, Inc. 09 Sep 2025 0 $0 3 Director 10 Sep 2025, 17:17
CMPS COMPASS Pathways plc 29 Jul 2025 1 $0 4 Director 30 Jul 2025, 16:25
CMPS COMPASS Pathways plc 29 Jul 2025 0 $0 3 Director 30 Jul 2025, 16:12
XENE Xenon Pharmaceuticals Inc. 05 Jun 2025 2 $0 4 Director 06 Jun 2025, 17:59
XENE Xenon Pharmaceuticals Inc. 05 Jun 2024 1 $0 4 Director 05 Jun 2024, 17:42
XENE Xenon Pharmaceuticals Inc. 10 Aug 2023 1 $0 4 Director 10 Aug 2023, 19:05
XENE Xenon Pharmaceuticals Inc. 08 Aug 2023 0 $0 3 Director 10 Aug 2023, 19:00
/report/000089924321018659-gover-justin-d-2021-05-05 GW PHARMACEUTICALS PLC 05 May 2021 19 $0 4 Chief Executive Officer, Director 07 May 2021, 16:15